RTGN Share Price Performance
US$3.54
1.94 (121.25%)
Price US$3.54
Share PriceUS$3.54
RetinalGenix Technologies Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
RTGN Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
RetinalGenix Technologies Inc. Key Details
About RTGN
- Founded
- 2017
- Employees
- n/a
- CEO
- WebsiteView website
RetinalGeniX Technologies Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ophthalmic, optical, and sight-threatening disorders. Its products include the Retinal Imaging Screening Device, a portable retinal imaging system providing a wide field of view without requiring pupil dilation; and RetinalCam, an in-home/remote location patient-activated monitoring and imaging device offering real-time communication and alerting system for physicians. It also develops RTG-2023 for the treatment of dry age-related macular degeneration; and RTG-2024 for the treatment of Alzheimer’s syndrome dementia. The company was incorporated in 2017 and is based in Apollo Beach, Florida. RetinalGenix Technologies Inc. is a subsidiary of Sanovas Ophthalmology, LLC.
